(Total Views: 720)
Posted On: 12/23/2022 12:44:49 PM
Post# of 148892
Someone noted that Kazem had been removed from Amarex’s website. I checked and they have a new President: David Lonza. Per LinkedIn, his experience is:
President Amarex Clinical Research
Dec 2022 - Present · 1 mo
Global Vice President - Health Sciences Division - NSF International ·
Sep 2022 - Present · 4 mos (He forgot to update present)
Lachman Consultant Services (Compliance, Regulatory, Science & Technology)
6 yrs 2 mos
You can see Lonza’s writeup on the Amarex website at this link:
https://www.amarexcro.com/about/leadership/david-lonza
CYDY is cooperating with the SEC. I wonder if Amarex is being fully transparent or if their legal team is limiting their cooperation due to the arbitration. Might Amarex be willing to bite the bullet and come clean in hopes of salvaging their reputation and future business? Lonza’s experience at Lachman might be relevant if they choose to clean up their act.
President Amarex Clinical Research
Dec 2022 - Present · 1 mo
Global Vice President - Health Sciences Division - NSF International ·
Sep 2022 - Present · 4 mos (He forgot to update present)
Lachman Consultant Services (Compliance, Regulatory, Science & Technology)
6 yrs 2 mos
You can see Lonza’s writeup on the Amarex website at this link:
https://www.amarexcro.com/about/leadership/david-lonza
CYDY is cooperating with the SEC. I wonder if Amarex is being fully transparent or if their legal team is limiting their cooperation due to the arbitration. Might Amarex be willing to bite the bullet and come clean in hopes of salvaging their reputation and future business? Lonza’s experience at Lachman might be relevant if they choose to clean up their act.
(3)
(0)Scroll down for more posts ▼
